DHR

#103
Danaher Corporation
198.12 USD
-0.21%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
197.28
199.00
Rango anual
180.03
242.75
Cambio diario
-0.21%
Variación mensual
+2.34%
Variación en los últimos 6 meses
-5.66%
Cambio anual
+4.83%
Cierres anteriores
198.53
Abrir
198.88
Bid
Ask
Mínimo
197.28
High
199.00
Volumen
1 546
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 140.1 B
  • Employee 60 K
  • Founded N/A
  • CEO Rainer M. Blair
  • Website www.danaher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BH3JF8
  • Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
45.33
Relación precio/flujo de caja
6.67

Danaher Corporation

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

Noticias